Company intelligence / Profile preview
Apricus Biosciences, Inc.
- Ownership
- Private
- Employees
- ~120
- Development stage
- Other
Overview
Apricus Biosciences developed innovative medicines primarily targeting sexual health and urology using its proprietary NexACT® drug delivery platform. Its lead product, Vitaros®, a topical treatment for erectile dysfunction, achieved approval and commercialization in Europe and Canada but failed to secure FDA approval. The company also advanced several other candidates including Fispemifene for male hypogonadism/lower urinary tract symptoms and Femprox for female sexual arousal disorder. In January 2019, Apricus merged with Seelos Therapeutics after years of financial challenges.
- Therapeutic areas
- CardiovascularMen's HealthEndocrinologyWomen's HealthOncology
- Modalities
- Small molecules (e.g., Vitaros topical cream)Selective estrogen receptor modulators (SERMs)Topical drug delivery via proprietary permeation technology (NexACT®)
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Apricus Biosciences, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apricus Biosciences, Inc..